Status:
COMPLETED
Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy
Lead Sponsor:
Heidelberg University
Conditions:
Invasive Aspergillosis
Eligibility:
All Genders
5-85 years
Brief Summary
Invasive pulmonary aspergillosis (IPA) remains a major cause for morbidity and mortality in patients (pts) with hematologic malignancies. As culture-based methods only yield results in a minority of p...
Detailed Description
Invasive pulmonary aspergillosis (IPA) remains a major cause for morbidity and mortality in patients (pts) with hematologic malignancies. As culture-based methods only yield results in a minority of p...
Eligibility Criteria
Inclusion
- immunocomprimised patients with high risk of invasive aspergillosis and lung infiltrates
- informed consent
Exclusion
- Children under the age of 5 years
- Informed consent not available
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT01448226
Start Date
January 1 2000
End Date
May 1 2011
Last Update
April 20 2020
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Innsbruck University Hospital
Innsbruck, Austria
2
Bielefeld evangelisches Krankenhaus
Bielefeld, Germany
3
Bochum University Hospital
Bochum, Germany
4
Cologne University Hospital
Cologne, Germany